Patient Rating:

4.5 out of 5

51 Patient Ratings
15 Patient Comments

Debra L. Simmons, M.D., M.S., FACE, FACP

Clinical Details

Schedule An Appointment Clinical Office Address
Clinical Neurosciences Center
175 North Medical Drive East
Salt Lake City, UT 84132
Map
(801) 581-7761 Utah Diabetes Center
615 Arapeen Drive, Suite 100
Salt Lake City, UT 84108

Bio

Dr. Debra Lynn Simmons is a professor of medicine at University of Utah and Director of Clinical Affairs, Utah Diabetes and Endocrinology Center.

Dr. Simmons is board certified in internal medicine as well as endocrinology, diabetes and metabolism and a diplomate of the American Board of Clinical Lipidology. In addition to her medical degree from Southwestern Medical School in Dallas, Texas, she holds a master’s degree in nutritional biochemistry from Cornell University in Ithaca, New York. After her residency at Indiana University Medical Center in Indianapolis, she completed her fellowship in endocrinology, diabetes and metabolism at the University of California, San Diego with expertise in lipid metabolism.

Dr. Simmons interests are diabetes and lipids with an emphasis on prevention of cardiovascular disease as well as education. She is principle investigator for NIH funded clinical trials including ALLHAT, ACCORD, AIMHIGH, SPRINT, ACCORDIAN and CIRT. She is active in medical education and is honored to have served nationally for the National Board of Medical Examiners, Association of Subspecialty Professors Education and Members Committees and as President of the Association of Program Directors in Endocrinology, Diabetes and Metabolism from 2005 to 2007. She was a member of the American Diabetes Association Professional Practice Committee that is responsible for updating the diabetes guidelines from 2012-2014. She is a member of the Finance and Audit Committee for the Endocrine Society.

Dr. Simmons was a clinical faculty member at University of California, San Diego before joining the faculty at University of Arkansas for Medical Sciences in Little Rock where she was promoted to professor of medicine with tenure. Dr. Simmons is listed in Who's Who in America and has been chosen for Best Doctors in America.

Board Certification and Academic Information

Academic Departments Internal Medicine - Professor
Academic Divisions Endocrinology and Metabolism
Board Certification American Board of Clinical Lipidology
American Board of Internal Medicine
American Board of Internal Medicine (Sub: Endocrinology, Diabetes & Metabolism)

Patient Ratings

The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

Likelihood of recommending care provider
4.5
My confidence in care provider
4.6
Time care provider spent with me
4.5
Care provider spoke using clear language
4.6
Care provider's effort to include me in decisions
4.6
Care provider's concern for questions & worries
4.5
Care provider's explanation of condition/problem
4.5
Wait time at clinic
4.0
Care provider's friendliness and courtesy
4.6

Patient Comments

Patient comments are gathered from our Press Ganey Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

June 05, 2014

Dr. Simmons is fantastic and very helpful. She explains things clearly and is friendly and understanding.

June 05, 2014

Dr. Simmons is very good and would highly recommend.

June 04, 2014

Dr. Klam and Dr. Simmons were both very forthcoming and friendly. I feel like I am in good hands.

May 08, 2014

In all of my visits with Dr Simmons, she has always been helpful with my needs and concerns. I appreciate that. She is personal and I enjoy my visits with her.

May 03, 2014

I was very impressed with both Cheryl and Dr Simmons cheerful attitude, with the attention they gave me, with their listening and understanding to my health challenges.

March 23, 2014

Dr Graham is a great diagnostician, he helped me a lot with my diabetes. It was difficult at times with getting followup information from the clinic when Sr Graham was not there

November 15, 2013

I made the mistake of bringing my Husband and he knows nothing about Diabetes. I was unable to convey some information and didn't absorb all the necessary information she had for me because He doesn't understand some of his comments were out of place and created confustion. Fortunately I have another appointment and my husband learned things that he was totally unaware of, if he retains them.

October 24, 2013

The thing that bothered me about the visit is that it probably wasnt even needed. The information she provided to me could have been communicated over the phone. I felt like it was a waste of my time to be there but more importantly the providers time for me to come to this follow up appointment. I feel like with a provider who only sees patients on one day during the week they should be very particular about what appointments they are making and keeping in regards to follow up care.

August 30, 2013

Dr. Simmons is a knowlegable physion, however she "overtalks" me (patient) and my wife when we are responding to questions or trying to clarify instructions.

August 09, 2013

she never showed up. I waited 2 hrs after my scheduled appt and finally left. I informed the nurse and an MA that had to leave. Dr never came in. this was extremely unprofessional. if I pulled that kind if stunt I would no long have a job.

June 20, 2013

Very discouraging to travel three hours to be told that basically nothing is wrong with me when infact there is clearly something medically wrong.

June 19, 2013

Dr Simmons was very thorough and spent the time needed to address my concerns. I am a new patient to Dr Simmons and I feel I have found a provider I feel comfortable with and provides patient centered care.

June 17, 2013

Dr. Miller is a wonderful Doctor. Very Knowledgeable about diabetes and how to care for it

May 13, 2013

first Dr. (intern) was so focussed on answering the questions she had preparrred she ignored questions I asked. The Sr. Dr. came in and told me I was "fine". I wasn't sure if she was referring to my health or because I was upset about being "forgotten" in the exam room twice in one day.

April 12, 2013

This doctor was unwilling, uninterested, and unable to engage with me in helping me evaluate my symptoms or healthcare concerns. I felt entirely and completely dismissed. This apathetic doctor couldn't be bothered with the work required to think. It took an incredible amount of energy to make and prepare for the appointment and now I am left with a miserable quality of life and don't know where to go to get help.

Academic Profile

Research Interests

  • Lipids
  • Hypertension
  • Primary and secondary prevention of cardiovascular disease
  • Diabetes
  • Education, Medical
  • Metabolic Syndrome

Board Certification and Academic Information

Academic Departments Internal Medicine - Professor
Academic Divisions Endocrinology and Metabolism
Board Certification American Board of Clinical Lipidology
American Board of Internal Medicine
American Board of Internal Medicine (Sub: Endocrinology, Diabetes & Metabolism)

Academic Office Locations

Academic Office Phone Number Academic Office Address
(801) 587-3926 Utah Diabetes and Endocrinology Center
Internal Medicine/Endocrinology, Diabetes and Metabolism
615 Arapeen Drive
Salt Lake City, UT 84108

Academic Bio

Dr. Debra Lynn Simmons is a professor of medicine at University of Utah and Director of Clinical Affairs, Utah Diabetes and Endocrinology Center.

Dr. Simmons is board certified in internal medicine as well as endocrinology, diabetes and metabolism and a diplomate of the American Board of Clinical Lipidology. In addition to her medical degree from Southwestern Medical School in Dallas, Texas, she holds a master’s degree in nutritional biochemistry from Cornell University in Ithaca, New York. After her residency at Indiana University Medical Center in Indianapolis, she completed her fellowship in endocrinology, diabetes and metabolism at the University of California, San Diego with expertise in lipid metabolism.

Dr. Simmons interests are diabetes and lipids with an emphasis on prevention of cardiovascular disease as well as education. She is principle investigator for NIH funded clinical trials including ALLHAT, ACCORD, AIMHIGH, SPRINT and ACCORDIAN. She is active in medical education and is honored to have served nationally for the National Board of Medical Examiners, Association of Subspecialty Professors Education and Members Committees and as President of the Association of Program Directors in Endocrinology, Diabetes and Metabolism from 2005 to 2007. She is a member of the American Diabetes Association Professional Practice Committee that is responsible for updating the diabetes guidelines.

Dr. Simmons was a clinical faculty member at University of California, San Diego before joining the faculty at University of Arkansas for Medical Sciences in Little Rock where she was promoted to professor of medicine with tenure. Dr. Simmons is listed in Who's Who in America and has been chosen for Best Doctors in America.

Education

Education History

Type School Degree
Fellowship University of California, San Diego
Endocrinology and Metabolism
Fellow
Internship/Residency Indiana University Medical Center
Internal Medicine
Intern/Resident
Professional Medical Southwestern Medical School
Medicine
M.D.
Graduate Training Cornell University
Nutritional Biochemistry
M.S.
Undergraduate University of Texas
Honors Liberal Arts, Plan II
B.A.

Publications

Selected Provider Publications

Journal Article

  1. Paradoxical reduction in HDL-C with fenofibrate and thiazolidinedione therapy in type 2 diabetes: the ACCORD Lipid Trial.Linz PE, Lovato LC, Byington RP, OConnor PJ, Leiter LA, Weiss D, Force RW, Crouse JR, Ismail-Beigi F, Simmons DL, Papademetriou V, Ginsberg HN, Elam MB (2014). Paradoxical reduction in HDL-C with fenofibrate and thiazolidinedione therapy in type 2 diabetes: the ACCORD Lipid Trial. Diabetes Care, 37(3), 686-93.
  2. Effect of Intensive Versus Standard Blood Pressure Control on Depression and Health-Related Quality of Life in Type 2 Diabetes: The ACCORD trial.OConnor PJ, Narayan KM, Anderson R, Feeney P, Fine L, Ali MK, Simmons DL, Hire DG, Sperl-Hillen JM, Katz LA, Margolis KL, Sullivan MD (2012). Effect of Intensive Versus Standard Blood Pressure Control on Depression and Health-Related Quality of Life in Type 2 Diabetes: The ACCORD trial. Diabetes Care, 35(7), 1479-81.
  3. Depression Predicts All-Cause Mortality: Epidemiological evaluation from the ACCORD HRQL substudy.Sullivan MD, OConnor P, Feeney P, Hire D, Simmons DL, Raisch DW, Fine LJ, Narayan KM, Ali MK, Katon WJ (2012). Depression Predicts All-Cause Mortality: Epidemiological evaluation from the ACCORD HRQL substudy. Diabetes Care.
  4. Severe hypoglycemia symptoms, antecedent behaviors, immediate consequences and association with glycemia medication usage: secondary analysis of the ACCORD clinical trial data.Bonds DE, Miller ME, Dudl J, Feinglos M, Ismail-Beigi F, Malozowski S, Seaquest E, Simmons DL, Sood A (2012). Severe hypoglycemia symptoms, antecedent behaviors, immediate consequences and association with glycemia medication usage: secondary analysis of the ACCORD clinical trial data. BMC Endocr Disord, 12(1), 5.
  5. Intensive Glycemic Control Is Not Associated With Fractures or Falls in the ACCORD Randomized Trial.Schwartz AV, Margolis KL, Sellmeyer DE, Vittinghoff E, Ambrosius WT, Bonds DE, Josse RG, Schnall AM, Simmons DL, Hue TF, Palermo L, Hamilton BP, Green JB, Atkinson HH, OConnor PJ, Force RW, Bauer DC (2012). Intensive Glycemic Control Is Not Associated With Fractures or Falls in the ACCORD Randomized Trial. Diabetes Care, 35(7), 1525-31.
  6. Cardiovascular risk assessment: addition of CKD and race to the Framingham equation.Drawz PE, Baraniuk S, Davis BR, Brown CD, Colon PJ Sr, Cujyet AB, Dart RA, Graumlich JF, Henriquez MA, Moloo J, Sakalayen MG, Simmons DL, Stanford C, Sweeney ME, Wong ND, Rahman M (2012). Cardiovascular risk assessment: addition of CKD and race to the Framingham equation. Am Heart J, 164(6), 925-31.e2.
  7. Barzilay JI, Davis BR, Pressel SL, Cutler JA, Einhorn PT, Black HR, Cushman WC, Ford CE, Margolis KL, Moloo J, Oparil S, Piller LB, Simmons DL, Whelton PK, Wong ND, and Wright, JT (2012). Long-Term Effects of Incident Diabetes Mellitus on Cardiovascular Outcomes in People Treated for Hypertension: The ALLHAT Diabetes Extension Study. Circulation. Cardiovascular Quality and Outcomes.
  8. Effect of intensive glycemic lowering on health-related quality of life in type 2 diabetes: ACCORD trial.Anderson RT, Narayan KM, Feeney P, Goff D Jr, Ali MK, Simmons DL, Sperl-Hillen JA, Bigger T, Cuddihy R, OConner PJ, Sood A, Zhang P, Sullivan MD (2011). Effect of intensive glycemic lowering on health-related quality of life in type 2 diabetes: ACCORD trial. Diabetes Care, 34(4), 807-12.
  9. Glycaemia and correlates of patient-reported outcomes in ACCORD trial participants.LID - 10.1111/j.1464-5491.2011.03532.x [doi]Ali MK, Feeney P, Hire D, Simmons DL, OConnor PJ, Ganz-Lord F, Goff D Jr, Zhang P, Andersen R, V Narayan KM, Sullivan MD (2011). Glycaemia and correlates of patient-reported outcomes in ACCORD trial participants.LID - 10.1111/j.1464-5491.2011.03532.x [doi]. Diabet Med.
  10. Anderson RT, Narayan KM, Feeney P, Goff D, Ali MK, Simmons DL, Sperl-Hillen JA, Bigger T, Cuddihy R, OConner PJ, Sood A, Zhang P, Sullivan MD (2011). Action to Control Cardiovascular Risk in Diabetes (ACCORD) Investigators. Effect of Intensive Glycemic Lowering on Health-related Quality of Life in Type 2 Diabetes Mellitus : ACCORD Trial. Diabetes Care, 34(4), 807-12.
  11. Kumar S, Burrows D, Dang S, Simmons D (2011). Sheehan’s Syndrome Presenting as Central Diabetes Insipidus: A Rare Presentation of an Uncommon Disorder. Endocr Pract, 17(1), 108-14.
  12. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study.Bonds DE, Miller ME, Bergenstal RM, Buse JB, Byington RP, Cutler JA, Dudl RJ, Ismail-Beigi F, Kimel AR, Hoogwerf B, Horowitz KR, Savage PJ, Seaquist ER, Simmons DL, Sivitz WI, Speril-Hillen JM, Sweeney ME (2010). The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study. BMJ, 340, b4909.
  13. Ismail-Beigi F, Craven T, Banerji MA, Basile J, Calles J, Cohen RM, Cuddihy R, Cushman WC, Genuth S, Grimm RH, Hamilton BP, Hoogwerf B, Karl D, Katz L, Krikorian A, OConnor P, Pop-Busui R, Schubart U, Simmons D, Taylor H, Thomas A, Weiss D, Hramiak I, ACCORD trial group (2010). Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet, 376, 419-460.

Book Chapter

  1. Agarwal M, Kantorovich V, Simmons DL (2013). Diabetes Mellitus. In Means K, Kortebein K, Buschbacher R, Eds. (Ed.), Geriatrics: Rehabilitation Medicine Quick Reference Series (pp. 80-83). New York: Desmos Medical Publishing.

Clinical Trials

Clinical Trials

Video & News